Cosmo Bio USA Suppliers


Worldwide
Cosmo Bio Co. Ltd. 
Home Algae (except Taiwan)
4BioDx (except Europe)
Yeastern Biotech
Cell Engineering Technologies
Biothelis (except EU and Japan)

North America only
Serumwerk
(Former Axis-Shield by Abbott
)
BQCkit
Ubiquigent

USA only
Cusabio 
Cusag
Koma Biotech
Larodan

USA Mexico and South America
Atlas Antibodies

About Cosmo Bio USA Suppliers:

Atlas Antibodies

vendor-image-atlasantibodies.jpg

Product Line-up
       Primary Antibodies

                PrecisA Monoclonals
                Triple A Polyclonals
                PrEST Antigen™

Supplier Name: Atlas Antibodies
Supplier Location: Sweeden
Founding Date: 2003
Distributed by Cosmo Bio USA Since: 2023
Supplier Website: www.atlasantibodies.com/
CBU Supplier Code (cat. no. prefix): ATL- 

About Atlas Antibodies

Atlas Antibodies is a Swedish biotechnology company driving leading research worldwide through providing affinity-purified monoclonal and polyclonal antibodies and control antigens. Their product portfolio extensively covers human proteins in cells, tissues, and organs.

With their roots in the Human Protein Atlas project, an integration of antibody-based imaging, proteomics, and transcriptomics, our antibodies are selective and specific for their target proteins through our extensive validation process, ensuring reproducible results.

They support you in your research. Our scientific support content and newsletter provide you with timely information about new product releases, research highlights, posters, infographics, and much more. In addition, their website contains informative whitepapers, protocols, guides, roundups of recent research papers, and blog posts.

They're growing fast, having acquired two companies in 2021. UK-based HistoCyte Laboratories produces high quality, reproducible cell line controls for same-slide use in histopathology available in multiple formats to suit your specific workflow and requirements. evitria is a world leading, global recombinant antibody expression service provider located in Zurich, Switzerland.

Vision

For every therapeutic discovery to be enhanced by our solutions.

Mission

Through our expertise and unique heritage, we provide innovative and high-quality solutions to researchers around the world.
By doing so we enable ground-breaking medical discovery, better diagnosis and patient outcomes.

Founded by researchers from the Human Protein Atlas

The Human Protein Atlas was initiated in 2003 by Swedish researchers, headed by Professor Mathias Uhlén, and is funded by the Knut and Alice Wallenberg foundation. It is a unique world-leading effort to create a complete map of human protein expression and localization in normal tissues, cancers, and cell lines. The project launched a first version of the complete human tissue proteome in 2016 as the Tissue Atlas, the subcellular proteome in 2017 and continues to add additional layers of knowledge exploring the human proteome.

Critical for the project's success was the availability of highly specific antibodies for all human proteins. As it was not possible to source all of the antibodies with the required quality needed, a standardized manufacturing process with rigorous quality control, was developed. The in-house development ensured that the antibodies met the high level of specificity and selectivity required for the project to succeed.

The first version of the Human Protein Atlas database was released at the Human Proteome Organizations (HUPO) meeting in 2005. It received an overwhelmingly positive response. Shortly afterward the Human Protein Atlas researchers started to be asked by fellow researchers if they could obtain the antibodies for use in their own research. This led to the establishment of Atlas Antibodies in 2006, to commercialize the antibodies developed by the Human Protein Atlas project.

Triple A Polyclonals, the antibodies from the Human Protein Atlas

These antibodies originating from the Human Protein Atlas project are available under the brand Atlas Antibodies Advanced Polyclonals (Triple A Polyclonals). The Triple A Polyclonals are since then been manufactured by Atlas Antibodies in our facilities in Sweden and distributed worldwide.​

PrecisA Monoclonals

PrecisA Monoclonals, precise, accurate and targeted monoclonal antibodies. In 2012, Atlas Antibodies started in-house development of mouse monoclonal antibodies against a selected number of targets. We have named them PrecisA Monoclonals to reflect both the core values at Atlas Antibodies and our Swedish origin. We offer a growing portfolio of monoclonals for use in various applications and research areas. The Swedish word "precisa" stands for precise, accurate and targeted. A perfect description of our mouse monoclonal antibodies.

PrEST Antigens

In 2014, we expanded our product offering to include PrEST Antigens, recombinant protein fragments used as immunogens for generating Triple A Polyclonals and PrecisA Monoclonals. The PrEST Antigens are recombinant human Protein Epitope Signature Tags (PrESTs), consisting of 50-150 amino acids, and are designed to have as low sequence identity as possible to other human proteins. The PrEST Antigens are provided as complements to our antibodies for control experiments.